Libmeldy

atidarsagene autotemcel · Orchard Therapeutics (Netherlands) B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Libmeldy, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: EMA Authorised: Libmeldy (atidarsagene autotemcel) — Orchard Therapeutics (Netherlands) B.V.